Skip to main content

SELLAS Life Sciences Group, Inc.

SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001390478

No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of SLS: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders3027−3
Shares1.86M1.73M−125.3K (−6.7%)
Value$17.1M$9.59M−$7.51M (−43.9%)

New holders (5)

Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to SLS in Q4 2021
InstitutionSharesValue% of portfolio
Ameriprise Financial Inc94,455$522.0K0.00%
Virtu Financial LLC13,935$77.0K0.01%
Gsa Capital Partners LLP10,447$58.0K0.01%
Simplex Trading, LLC6,948$38.0K0.00%
Amplius Wealth Advisors, LLC5$00.00%

Sold out (8)

Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of SLS in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Bank of Montreal110,192$1.08M
Jane Street Group, LLC20,367$186.0K
Jump Financial, LLC14,627$134.0K
Millennium Management LLC12,161$111.0K
Global Retirement Partners, LLC1,000$9.00K
Harbour Investments, Inc.200$2.00K
FMR LLC96$1.00K
Cutler Group LP200$1.00K